These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19521923)

  • 1. Development of hepatocellular carcinoma in elderly patients with chronic hepatitis C with or without elevated aspartate and alanine aminotransferase levels.
    Kobayashi M; Suzuki F; Akuta N; Suzuki Y; Sezaki H; Yatsuji H; Kawamura Y; Hosaka T; Kobayashi M; Arase Y; Ikeda K; Mineta R; Iwasaki S; Watahiki S; Miyakawa Y; Kumada H
    Scand J Gastroenterol; 2009; 44(8):975-83. PubMed ID: 19521923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High serum alanine aminotransferase levels for the first three successive years can predict very high incidence of hepatocellular carcinoma in patients with Child Stage A HCV-associated liver cirrhosis.
    Miyakawa K; Tarao K; Ohshige K; Morinaga S; Ohkawa S; Okamoto N; Shibuya A; Adachi S; Miura Y; Fujiyama S; Miyase S; Tomita K
    Scand J Gastroenterol; 2009; 44(11):1340-8. PubMed ID: 19891585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction therapy of alanine aminotransferase levels prevent HCC development in patients with HCV-associated cirrhosis.
    Rino Y; Tarao K; Morinaga S; Ohkawa S; Miyakawa K; Hirokawa S; Masaki T; Tarao N; Yukawa N; Saeki H; Takanashi Y; Imada T
    Anticancer Res; 2006; 26(3B):2221-6. PubMed ID: 16821591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of elderly hepatitis C virus-associated hepatocellular carcinoma patients.
    Kumada T; Toyoda H; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Tada T; Tanaka J
    J Gastroenterol Hepatol; 2013 Feb; 28(2):357-64. PubMed ID: 23190084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
    Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alanine aminotransferase (ALT) levels in a normal population and interferon therapy in chronic hepatitis C patients with normal ALT.
    Sakugawa H; Nakasone H; Nakayoshi T; Kawakami Y; Yamashiro T; Maeshiro T; Kinjo F; Saito A; Yakabi S
    Hepatogastroenterology; 2003; 50(49):165-9. PubMed ID: 12630015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between sustained elevation of serum alanine aminotransferase and progression from cirrhosis to hepatocellular carcinoma: comparison in patients with hepatitis B virus- and hepatitis C virus-associated cirrhosis.
    Sato A; Kato Y; Nakata K; Nakao K; Daikoku M; Ishii N; Matsumoto T; Iseki K; Mazume H; Nagataki S
    J Gastroenterol Hepatol; 1996 Oct; 11(10):944-8. PubMed ID: 8912132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained low alanine aminotransferase levels can predict the survival for 10 years without hepatocellular carcinoma development in patients with hepatitis C virus-associated liver cirrhosis of child stage A.
    Tarao K; Rino Y; Ohkawa S; Endo O; Miyakawa K; Tamai S; Hirokawa S; Masaki T; Nagaoka T; Okamoto N; Tanaka K; Tarao N
    Intervirology; 2004; 47(2):65-71. PubMed ID: 15192269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load.
    Tseng TC; Liu CJ; Yang HC; Su TH; Wang CC; Chen CL; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH
    Gastroenterology; 2012 May; 142(5):1140-1149.e3; quiz e13-4. PubMed ID: 22333950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
    Pekow JR; Bhan AK; Zheng H; Chung RT
    Cancer; 2007 Jun; 109(12):2490-6. PubMed ID: 17487861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased risk of hepatocellular carcinoma in patients with chronic hepatitis C whose serum alanine aminotransferase levels became less than twice the upper limit of normal following interferon therapy.
    Moriyama M; Matsumura H; Aoki H; Shimizu T; Yamagami H; Shioda A; Kaneko M; Goto I; Tanaka N; Arakawa Y
    Liver Int; 2005 Feb; 25(1):85-90. PubMed ID: 15698403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of serum alanine aminotransferase and aspartate aminotransferase levels to liver histology in chronic hepatitis C.
    Nadeem A; Hussain MM; Aslam M
    J Coll Physicians Surg Pak; 2010 Oct; 20(10):657-61. PubMed ID: 20943107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of chronic hepatitis B REVEALed.
    Chen CJ; Yang HI
    J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
    Tarao K; Fujiyama S; Ohkawa S; Miyakawa K; Tamai S; Hirokawa S; Masaki T; Tanaka K
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):164-9. PubMed ID: 15668491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of elevated alpha-fetoprotein in Alaskan Native patients with chronic hepatitis C.
    Bruce MG; Bruden D; McMahon BJ; Christensen C; Homan C; Sullivan D; Deubner H; Williams J; Livingston SE; Gretch D
    J Viral Hepat; 2008 Mar; 15(3):179-87. PubMed ID: 18233991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redistribution of regulatory T-cells across the evolving stages of chronic hepatitis C.
    Ferri S; Lalanne C; Lanzoni G; Bassi M; Asioli S; Cipriano V; Pappas G; Muratori P; Lenzi M; Muratori L
    Dig Liver Dis; 2011 Oct; 43(10):807-13. PubMed ID: 21684822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of hepatocellular carcinoma in hepatitis C carriers with normal alanine aminotransferase levels.
    Kumada T; Toyoda H; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Atsumi H; Takagi M; Nakano S; Arakawa T; Fujimori M
    J Hepatol; 2009 Apr; 50(4):729-35. PubMed ID: 19232448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of hepatocellular carcinoma in patients with chronic hepatitis B virus infection who have normal alanine aminotransferase values.
    Kumada T; Toyoda H; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Atsumi H; Takagi M; Arakawa T; Fujimori M
    J Med Virol; 2010 Apr; 82(4):539-45. PubMed ID: 20166172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of elevated alpha-foetoprotein (AFP) in patients with chronic hepatitis C without hepatocellular carcinoma in upper EGYPT.
    Kobeisy MA; Morsy KH; Galal M; Sayed SK; Ashmawy MM; Mohammad FM
    Arab J Gastroenterol; 2012 Jun; 13(2):49-53. PubMed ID: 22980591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.